Portfolio
Corner Office
Culture
Premium
Opinion
Events
Innovation
Subscribe
Sign In
Register
Menu
Subscribe
Sign In
Register
Portfolio
Corner Office
Culture
Premium
Opinion
Events
Innovation
Subscribe
Sign In
Register
Search Query
Submit Search
Show Search
Hedge Funds
Hedge Funds
Biopharma Funds Are in Sick Bay
Most health care and related funds lost money in February.
Stephen Taub
March 12, 2025 03:56 AM
Premium
Top Performer Sosin Partners Braces for Possible Roadblock
Stephen Taub
February 20, 2025
Hedge Funds
The Stocks Stan Druckenmiller Just Bought
Stephen Taub
February 19, 2025
Premium
Top Hedge Funds Bet Big: D1, Lone Pine, Maverick, Viking Make Major Moves
Steve Taub
February 18, 2025
Hedge Funds
Tiger Cub Robert Citrone Gears Up for a Stock Market Correction
Stephen Taub
February 13, 2025
Premium
As Sentiment Shifts, Jeffrey Talpins’s Macro Fund Exits Stocks
Steve Taub
February 12, 2025
Premium
Volatile Macro Fund Haidar Leads Peers With Double-Digit Gain
Steve Taub
February 11, 2025
Premium
D1 Capital Leads the Tiger Crowd in January
Steve Taub
February 10, 2025
Hedge Funds
Despite the Administration’s ‘Unconventional Approach,’ Dan Loeb Is Still Bullish for 2025
Stephen Taub
February 6, 2025
Premium
Biopharma IPO Interest Peaks Following Strong Reception
Steve Taub
February 4, 2025
Hedge Funds
A Value-Driven Hedge Fund’s Strong Start
Stephen Taub
February 3, 2025